We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hamburg: ANDA Backlog Holding Up First-to-Market Generics
Hamburg: ANDA Backlog Holding Up First-to-Market Generics
March 18, 2011
FDA Commissioner Margaret Hamburg has revealed new details on the agency’s backlog of generic-drug applications, saying that more than 350 of those ANDAs are for products that would be the first generic version of a drug on the market.